OverviewSuggest Edit

Alteogen is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADCs), and monoclonal antibody biosimilars. It provides NexP fusion technology that supports the production of Human Growth Hormone (HGH), long-acting exenatide (for diabetes), and long-acting Factor VIIa (for hemophilia).
TypePublic
Founded2008
Websitealteogen.com

Latest Updates

Share Price (Nov 2020)₩164.4 K(+3%)
Cybersecurity ratingBMore

Alteogen Financials and Metrics

Alteogen Revenue

Market capitalization (27-Nov-2020)

2.2t

Closing stock price (27-Nov-2020)

164.4k
Alteogen's current market capitalization is ₩2.2 t.
Show all financial metrics

Alteogen Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Alteogen Online and Social Media Presence

Embed Graph

Alteogen Frequently Asked Questions

  • When was Alteogen founded?

    Alteogen was founded in 2008.

  • Who are Alteogen competitors?

    Competitors of Alteogen include WinSanTor, Abarceo Pharma and REMD Biotherapeutics.